Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 May;54(5):2063-9.
doi: 10.1128/AAC.01569-09. Epub 2010 Mar 15.

Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges

Affiliations
Comparative Study

Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges

Steven D Brown et al. Antimicrob Agents Chemother. 2010 May.

Abstract

This study assessed the spectrum of activity of torezolid (TR-700), the active moiety of torezolid phosphate (TR-701), and proposes tentative MIC and disk diffusion breakpoints as well as quality control ranges. The in vitro susceptibilities of 1,096 bacterial isolates, representing 23 different species or phenotypic groups, were determined for torezolid, linezolid, cefotaxime, and levofloxacin using Clinical and Laboratory Standards Institute (CLSI) broth microdilution MICs, minimum bactericidal concentrations (MBCs), agar dilution, and disk diffusion testing methods. Torezolid was very active against the majority of Gram-positive strains, including methicillin-susceptible and -resistant Staphylococcus aureus (MIC(50) = 0.25 microg/ml, MIC(90) <or= 0.5 microg/ml), coagulase-negative staphylococci (CNS; MIC(50) = 0.25 microg/ml, MIC(90) <or= 0.5 microg/ml), enterococci (MIC(50) and MIC(90) <or= 0.5 microg/ml), and streptococci (MIC(50) and MIC(90) <or= 0.25 microg/ml). Based upon MIC(90)s, torezolid was 4-fold more active than linezolid against S. aureus, coagulase-negative staphylococci, and the enterococci and 8-fold more active than linezolid against the streptococci. With the use of tentative MIC breakpoints of <or=2 microg/ml for susceptibility, torezolid disk diffusion zone diameter breakpoints are proposed using a 20-microg disk. In addition, MIC quality control ranges of torezolid were determined for three CLSI-recognized standard ATCC reference strains.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Scattergrams of torezolid versus zone diameters (20-μg disks). (A) All staphylococci combined using transmitted light (n = 338). (B) All staphylococci combined using reflected light (n = 338). (C) Enterococcal species combined (n = 202). (D) All streptococci combined (n = 361). Horizontal lines represent proposed susceptible (lower line), susceptible-only, and resistant (upper line) MIC breakpoints; vertical lines represent proposed susceptible (right line), susceptible-only, and resistant (left line) zone diameter breakpoints. Abbreviations: n, number of strains tested; VM, very major errors; M, major errors; m, minor errors; n.a., not applicable; R, resistant; S, susceptible.
FIG. 2.
FIG. 2.
Bar graph (left) and scattergram (right) showing torezolid broth microdilution MICs versus torezolid agar dilution MICs for S. aureus (n = 104), Enterococcus spp. (n = 105), and S. pneumoniae (n = 106). Vertical bars represent ±1 doubling dilution from complete agreement.

References

    1. Brown, S. D., and M. M. Traczewski. 2008. Relative potency of TR-700, the active moiety of prodrug TR-701, against selected bacterial pathogens and provisional disk test criteria, abstr. F1-2069. Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)-Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet. American Society for Microbiology and Infectious Diseases Society of America, Washington, DC.
    1. Brunden, M. N., G. E. Zurenko, and B. Kapik. 1992. Modification of the error-bounded classification scheme for use with two MIC breakpoints. Diagn. Microbiol. Infect. Dis. 15:135-140. - PubMed
    1. Choi, S., T. Lee, W. Im, J. Rhee, and W. Kim. 2004. Comparative antibacterial activity of DA-70218, a new oxazolidinone, abstr F-1417. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
    1. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.

Publication types

MeSH terms

LinkOut - more resources